[June 24, 2016]

INVESTOR ALERT: Investigation of Chiasma, Inc. Announced by the Law Firm Goldman Scarlato & Penny, P.C.; Investors Encouraged to Contact the Firm

Goldman Scarlato & Penny, P.C. announces an investigation on behalf of shareholders of Chiasma, Inc. ("Chiasma" or the "Company")(NASDAQ:CHMA) concerning potential violations of the federal securities laws by the Company and company insiders. The investigation focuses on whether misleading information about the Cmpany's new drug, Mycapssa, and issues related to the Company's application to the FDA to obtain approval for the drug was provided to investors between July 15, 2015 and April 17, 2016.

If you purchased Chiasma shares between July 15, 2015 and April 17, 2016 and would like more information about how class actions work, what role you can play in a class action, this ongoing investigation of Chiasma, or if you have information relevant to the investigation, you are encouraged to contact Mark Goldman, Esq. at [email protected] or call (484) 342-0700.

The attorneys of Goldman Scarlato & Penny, P.C. bring over 25 years of experience investigating and litigating securities fraud cases in courts throughout the country. Please visit our website, www.lawgsp.com for more information about the Firm and our attorneys.

This press release may be considered Attorney Advertising in some jurisdictions, under applicable laws and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160624005753/en/

[ Back To TMCnet.com's Homepage ]